Medicare Enrolled

Dr. Jesse Karpman, MD

Pulmonary Disease · Union, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2333 MORRIS AVENUE, Union, NJ 07083
9089641964
In practice since 2006 (19 years)
NPI: 1801997515 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Karpman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Karpman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Karpman

Dr. Jesse Karpman is a pulmonary disease specialist in Union, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Karpman performed 1,420 Medicare services across 830 unique beneficiaries.

Between the years covered by Open Payments, Dr. Karpman received a total of $4,954 from 24 pharmaceutical and/or device companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Karpman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 50% volume in NJ $4,954 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,420
Medicare services
Top 50% in NJ for pulmonary disease
830
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~75 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
378 $101 $363
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
325 $24 $127
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
222 $156 $487
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
209 $50 $195
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
207 $39 $155
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
63 $127 $551
New patient office visit, complex (60-74 min) 16 $192 $691
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,954
Total received (2018-2024)
Avg $708/year across 7 years
Top 31% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
304
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,954 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$860
2023
$912
2022
$802
2021
$700
2020
$612
2019
$574
2018
$494

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$340
AstraZeneca Pharmaceuticals LP
$179
Bayer Healthcare Pharmaceuticals Inc.
$93
Mylan Specialty L.P.
$93
Regeneron Healthcare Solutions, Inc.
$50
United Therapeutics Corporation
$47
Inspire Medical Systems, Inc.
$25
Mallinckrodt Hospital Products Inc.
$16
GENZYME CORPORATION
$16
Top 3 companies account for 71.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,940
AstraZeneca Pharmaceuticals LP
$823
Actelion Pharmaceuticals US, Inc.
$266
Bayer HealthCare Pharmaceuticals Inc.
$224
Mylan Specialty L.P.
$222
GENZYME CORPORATION
$217
Boehringer Ingelheim Pharmaceuticals, Inc.
$212
PFIZER INC.
$187
Bayer Healthcare Pharmaceuticals Inc.
$155
Sunovion Pharmaceuticals Inc.
$152
Regeneron Healthcare Solutions, Inc.
$121
United Therapeutics Corporation
$74
Gilead Sciences, Inc.
$63
Philips Electronics North America Corporation
$62
Insmed, Inc.
$43
Genentech USA, Inc.
$38
Teva Pharmaceuticals USA, Inc.
$25
Inspire Medical Systems, Inc.
$25
Grifols USA, LLC
$24
Advanced Respiratory, Inc
$21
ADVANCED RESPIRATORY, INC
$17
Mallinckrodt Hospital Products Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$15
Optinose US, Inc.
$11
Top 3 companies account for 61.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · ArmonAir Digihaler · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CINQAIR · DUPIXENT · ELIQUIS · Esbriet · FASENRA · GLASSIA · INSPIRE · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Prolastin-C Liquid · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON NEOHALER · Utibron · Xhance · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Union?
Compare pulmonary diseases in the Union area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
585
Per 100K population
102.2
County median income
$100,117
Nearest hospital
NEWARK BETH ISRAEL MEDICAL CENTER
3.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Karpman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Karpman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Karpman performed 378 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Karpman receive payments from pharmaceutical companies?
Yes. Dr. Karpman received a total of $4,954 from 24 companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Karpman's costs compare to other pulmonary diseases in Union?
Dr. Karpman's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Karpman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →